Design Optimization in Nonlinear Mixed Effects Models Using Cost Functions: Application to a Joint Model of Infliximab and Methotrexate Pharmacokinetics - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Communications in Statistics - Theory and Methods Année : 2009

Design Optimization in Nonlinear Mixed Effects Models Using Cost Functions: Application to a Joint Model of Infliximab and Methotrexate Pharmacokinetics

Résumé

We address the problem of design optimization using cost functions in nonlinear mixed effects models with multiple responses. We focus on the relative feasibility of the optimized designs, in term of sampling times and of number of subjects. To do that, we extend the Fedorov–Wynn algorithm—a dedicated design optimization algorithm—to include a cost function that penalizes less feasible designs as well as to take into account multiple responses. We apply this extension to the design optimization of a joint pharmacokinetic model of infliximab and methotrexate administered in rheumatoid arthritis. We show the benefit of such an approach when substantial constraints on the design are imposed.
Fichier principal
Vignette du fichier
Retout_Comm_in_stat_2009.pdf (816.81 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-00424247 , version 1 (15-02-2010)

Identifiants

Citer

Sylvie Retout, Emmanuelle Comets, Caroline Bazzoli, France Mentré. Design Optimization in Nonlinear Mixed Effects Models Using Cost Functions: Application to a Joint Model of Infliximab and Methotrexate Pharmacokinetics: Designs in nonlinear mixed effects models. Communications in Statistics - Theory and Methods, 2009, 8, pp.3351-3368. ⟨10.1080/03610920902833511⟩. ⟨inserm-00424247⟩

Collections

INSERM UNIV-PARIS7
137 Consultations
308 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More